Home / EDTXF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does EDTXF make money? Does EDTXF have pricing power? What's the Earnings Whisper? Will EDTXF profit more as the business scales? What is EDTXF's management track record? Is EDTXF's current price justified?

Spectral Medical Inc

$0.91 -$0.13 (-12.88%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.91

Day Range

$0.91$0.92

Year Range

$0.81$1.21

Market Cap

265.96M

AVG Volume

9.44K

Trailing/Forward PE

-9.8/44.11

PEG ratio

0.05

Dividend Yield

Next Earnings Date

2026-11-06

Primary Exchange

Other OTC

Revenue (CAD) · TTM

EDTXF Revenue (CAD) · TTM by quarter
Period	Revenue (CAD) · TTM
26 Q2	2.57M
26 Q1	2.76M
25 Q4	2.44M
25 Q3	2.71M
25 Q2	2.53M
25 Q1	2.19M
24 Q4	2.29M
24 Q3	2.01M
24 Q2	1.9M
24 Q1	1.74M

Net Income (CAD) · TTM

EDTXF Net Income (CAD) · TTM by quarter
Period	Net Income (CAD) · TTM
26 Q2	-35.77M
26 Q1	-38.03M
25 Q4	-47.69M
25 Q3	-41.7M
25 Q2	-21.38M
25 Q1	-23.85M
24 Q4	-15.4M
24 Q3	-25.11M
24 Q2	-18.51M
24 Q1	-18.05M

Operating Income (CAD) · TTM

EDTXF Operating Income (CAD) · TTM by quarter
Period	Operating Income (CAD) · TTM
26 Q2	-11.08M
26 Q1	-11.39M
25 Q4	-11.54M
25 Q3	-11.71M
25 Q2	-11.68M
25 Q1	-13.77M
24 Q4	-12.55M
24 Q3	-13.06M
24 Q2	-12.9M
24 Q1	-12.35M

EBITDA (CAD) · TTM

EDTXF EBITDA (CAD) · TTM by quarter
Period	EBITDA (CAD) · TTM
26 Q2	-32.39M
26 Q1	-35.22M
25 Q4	-43.35M
25 Q3	-36.83M
25 Q2	-16.9M
25 Q1	-19.87M
24 Q4	-10.6M
24 Q3	-17.83M
24 Q2	-11.75M
24 Q1	-12.02M

Cash Flows (CAD) · TTM

EDTXF Cash Flows (CAD) · TTM by quarter
Period	Cash Flows (CAD) · TTM
26 Q2	-10.95M
26 Q1	-11.15M
25 Q4	-10.19M
25 Q3	-9.14M
25 Q2	-9.35M
25 Q1	-9.04M
24 Q4	-8.85M
24 Q3	-8.39M
24 Q2	-8.71M
24 Q1	-8.65M

EPS (CAD) · TTM

EDTXF EPS (CAD) · TTM by quarter
Period	EPS (CAD) · TTM
26 Q2	-0.13
26 Q1	-0.14
25 Q4	-0.17
25 Q3	-0.15
25 Q2	-0.08
25 Q1	-0.08
24 Q4	-0.06
24 Q3	-0.09
24 Q2	-0.07
24 Q1	-0.06

Expenses (CAD) · TTM

EDTXF Expenses (CAD) · TTM by quarter
Period	Expenses (CAD) · TTM
26 Q2	6.73M
26 Q1	9.2M
25 Q4	12.53M
25 Q3	14.01M
25 Q2	14.61M
25 Q1	15.23M
24 Q4	14.72M
24 Q3	15.66M
24 Q2	15.88M
24 Q1	15.16M

Shares Outstanding · TTM

EDTXF Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-2.47M
26 Q1	-2.48M
25 Q4	-2.12M
25 Q3	-2.08M
25 Q2	-1.99M
25 Q1	-2.76M
24 Q4	-1.68M
24 Q3	-1.69M
24 Q2	-1.78M
24 Q1	-1.69M

Dividends (CAD)

EDTXF Dividends (CAD) by quarter
Period	Dividends (CAD)
Dec 11	0.12

Free Cash Flow Yield

EDTXF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-3.02%
Sep 26	-3%
Aug 26	-2.82%
Aug 26	-2.84%
Aug 26	-2.71%
Aug 26	-2.73%
Jul 26	-2.74%
Jul 26	-2.76%
Jul 26	-2.71%
Jul 26	-2.75%
Jul 26	-2.85%
Jun 26	-2.6%
Jun 26	-2.56%
Jun 26	-2.54%
Jun 26	-2.46%
May 26	-2.44%
May 26	-2.5%
May 26	-2.49%
May 26	-2.48%
May 26	-2.59%
Apr 26	-2.51%
Apr 26	-2.5%
Apr 26	-2.5%
Apr 26	-2.51%
Mar 26	-2.23%
Mar 26	-2.53%
Mar 26	-2.48%
Mar 26	-2.36%
Feb 26	-2.41%
Feb 26	-2.42%
Feb 26	-2.44%
Feb 26	-2.41%
Jan 26	-2.49%
Jan 26	-2.37%
Jan 26	-2.29%
Jan 26	-2.22%
Jan 26	-2.23%
Dec 25	-2.58%
Dec 25	-2.64%
Dec 25	-2.56%
Dec 25	-2.54%
Nov 25	-2.61%
Nov 25	-2.45%
Nov 25	-2.3%
Nov 25	-2.29%
Oct 25	-2.21%
Oct 25	-2.09%
Oct 25	-2.13%
Oct 25	-2.28%
Oct 25	-2.29%
Sep 25	-2.13%
Sep 25	-2.13%
Sep 25	-1.85%
Sep 25	-1.96%
Aug 25	-2.14%
Aug 25	-2.27%
Aug 25	-2.89%
Aug 25	-3.91%
Aug 25	-3.75%
Jul 25	-3.8%
Jul 25	-3.87%
Jul 25	-3.72%
Jul 25	-3.9%
Jun 25	-3.78%
Jun 25	-3.77%
Jun 25	-3.63%
Jun 25	-3.81%
May 25	-3.73%
May 25	-3.75%
May 25	-3.87%
May 25	-3.64%
May 25	-4%
Apr 25	-4.04%
Apr 25	-3.94%
Apr 25	-4.44%
Apr 25	-4.43%
Mar 25	-4.03%
Mar 25	-4.48%
Mar 25	-4.3%
Mar 25	-4.2%
Feb 25	-4.41%
Feb 25	-4.6%
Feb 25	-4.75%
Feb 25	-5.27%
Jan 25	-5.58%
Jan 25	-5.5%
Jan 25	-5.98%
Jan 25	-5.34%
Jan 25	-5.47%
Dec 24	-6.32%
Dec 24	-6.73%
Dec 24	-6.25%
Dec 24	-5.93%
Nov 24	-5.42%
Nov 24	-6%
Nov 24	-5.44%
Nov 24	-5.46%
Nov 24	-5.12%
Oct 24	-4.49%
Oct 24	-5.11%

Price to Sales

EDTXF Price to Sales by quarter
Period	Price to Sales
Sep 26	133.35
Sep 26	134.51
Aug 26	142.86
Aug 26	142.27
Aug 26	148.7
Aug 26	147.9
Jul 26	147.07
Jul 26	145.97
Jul 26	148.79
Jul 26	146.6
Jul 26	141.39
Jun 26	160.64
Jun 26	162.96
Jun 26	164.43
Jun 26	169.84
May 26	171.3
May 26	166.69
May 26	167.49
May 26	168.26
May 26	161.08
Apr 26	166.52
Apr 26	166.8
Apr 26	166.98
Apr 26	166.27
Mar 26	151.78
Mar 26	133.29
Mar 26	136.38
Mar 26	143.41
Feb 26	140.32
Feb 26	139.69
Feb 26	138.65
Feb 26	140.23
Jan 26	135.79
Jan 26	142.4
Jan 26	147.6
Jan 26	151.99
Jan 26	151.45
Dec 25	143.06
Dec 25	140.12
Dec 25	144.18
Dec 25	145.26
Nov 25	141.48
Nov 25	150.53
Nov 25	160.89
Nov 25	161.19
Oct 25	167
Oct 25	176.34
Oct 25	173.49
Oct 25	162.21
Oct 25	161.61
Sep 25	193.92
Sep 25	193.39
Sep 25	223.2
Sep 25	210.3
Aug 25	192.92
Aug 25	181.49
Aug 25	142.79
Aug 25	105.51
Aug 25	110.16
Jul 25	108.6
Jul 25	106.56
Jul 25	110.99
Jul 25	105.75
Jun 25	102.26
Jun 25	102.62
Jun 25	106.55
Jun 25	101.5
May 25	103.69
May 25	103.25
May 25	100
May 25	106.2
May 25	96.8
Apr 25	95.68
Apr 25	98.21
Apr 25	87.14
Apr 25	87.4
Mar 25	103.89
Mar 25	93.35
Mar 25	97.29
Mar 25	99.64
Feb 25	94.91
Feb 25	90.89
Feb 25	88.09
Feb 25	79.41
Jan 25	75.01
Jan 25	76.07
Jan 25	69.93
Jan 25	78.4
Jan 25	76.41
Dec 24	72.53
Dec 24	68.1
Dec 24	73.36
Dec 24	77.34
Nov 24	84.55
Nov 24	76.43
Nov 24	84.23
Nov 24	83.97
Nov 24	89.56
Oct 24	102.01
Oct 24	89.65

Price/Operating Cashflow

EDTXF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Dec 20	72.96
Dec 20	80.98
Dec 20	70
Dec 20	68.71
Nov 20	69.72
Nov 20	67.83
Nov 20	76.09
Nov 20	73.05
Oct 20	67.45
Oct 20	73.31
Oct 20	79.77
Oct 20	84.24
Oct 20	89.42
Sep 20	50.66
Sep 20	56.32
Sep 20	56.15
Sep 20	58.08
Aug 20	59.89
Aug 20	58.64
Aug 20	60.29
Aug 20	60.11
Jul 20	57.34
Jul 20	56.85
Jul 20	61.79
Jul 20	59.18
Jul 20	64.7

Price to Book

EDTXF Price to Book by quarter
Period	Price to Book
Sep 22	57.12
Sep 22	56.29
Sep 22	55.71
Sep 22	55.59
Aug 22	55.19
Aug 22	52.37
Aug 22	60.61
Aug 22	67.04
Jul 22	65.52
Jul 22	68.08
Jul 22	52.58
Jul 22	45.13
Jul 22	49.64
Jun 22	26.37
Jun 22	26.81
Jun 22	20.13
Jun 22	20.64
May 22	17.29
May 22	19.37
May 22	19.55
May 22	20.46
Apr 22	20.67
Apr 22	22.51
Apr 22	22.31
Apr 22	22.27
Apr 22	19.31
Mar 22	12.17
Mar 22	14.33
Mar 22	14.43
Mar 22	14.53
Feb 22	13.27
Feb 22	14.34
Feb 22	13.81
Feb 22	12.3
Jan 22	10.62
Jan 22	10.62
Jan 22	12.04
Jan 22	10.63
Dec 21	8.94
Mar 21	89.17
Mar 21	93.68
Mar 21	86.64
Mar 21	110.99
Feb 21	112.59
Feb 21	115.66
Feb 21	117.07
Feb 21	100.47
Jan 21	82.74
Jan 21	74.29
Jan 21	71.46
Jan 21	75.48
Dec 20	70.9
Dec 20	31.25
Dec 20	34.69
Dec 20	29.99
Dec 20	29.44
Nov 20	29.86
Nov 20	29.06
Nov 20	32.6
Nov 20	31.29
Oct 20	28.89
Oct 20	31.4
Oct 20	34.17
Oct 20	36.08
Oct 20	38.3
Sep 20	357.54
Sep 20	397.5
Sep 20	396.25
Sep 20	409.88
Aug 20	422.69
Aug 20	413.85
Aug 20	425.46
Aug 20	424.25
Jul 20	404.68
Jul 20	401.21
Jul 20	436.08
Jul 20	417.67
Jul 20	456.63
Jun 20	56.21
Jun 20	61.75
Jun 20	64.73
Jun 20	64.36
May 20	63.29
May 20	64.37
May 20	66.27
May 20	68.29
May 20	66.87
Apr 20	61.52
Apr 20	67.03
Apr 20	51.66
Apr 20	50.9
Mar 20	30.17
Mar 20	29.33
Mar 20	29.57
Mar 20	39.7
Feb 20	41.4
Feb 20	42.4
Feb 20	46.74
Feb 20	45.8
Jan 20	42.94

No video analysis for this stock yet. Request one from our team.

News: EDTXF

globenewswire.com · 25 Jun 2026

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that the U.S. Food and Drug Administration (“FDA”) has completed its filing review and formally filed the Company's Premarket Approval (“PMA”) application for PMX, the Company's endotoxin removal therapy for patients with endotoxic septic shock (“ESS”). FDA acceptance for filing of the PMA application follows completion of the Agency's filing review process and confirms that the application contains all the information needed to proceed with the substantive review.

AI Analysis

Spectral Medical Inc

Video analysis: EDTXF

News: EDTXF

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

Similar companies